Does cardiac resynchronization therapy benefit patients with ischemic and non-ischemic cardiomyopathy similarly?

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4378-4380

  Makki, Nader ^a   Swaminathan, Paari Dominic ^b   Olshansky, Brian ^a  

^a UNIVERSITY OF IOWA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

All cause mortality; Cardiac resynchronization therapy; Re hospitalization for cardiovascular causes; Re hospitalization for heart failure

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CAUSE OF DEATH; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HOSPITALIZATION; HUMAN; IMPLANTATION; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LETTER; MAJOR CLINICAL STUDY; MORTALITY; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QRS COMPLEX; SYSTEMATIC REVIEW; THERAPY EFFECT; CARDIOMYOPATHY; COMPARATIVE STUDY; COMPLICATION; HEART MUSCLE ISCHEMIA; META ANALYSIS;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHIES; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 84886234371     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.05.052     Document Type: Article

References (12)

1. W.T. Abraham, W.G. Fisher, and A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
2. M. Becker, C. Zwicker, and M. Kaminsky Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position J Am Coll Cardiol Img 4 4 2011 366 374
3. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
4. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
5. A.J. Moss, W.J. Hall, and D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
6. J.G. Cleland, J.C. Daubert, and E. Erdmann Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
7. M.R. Bristow, A.M. Feldman, and L.A. Saxon Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators J Card Fail 6 2000 276 285
8. C. Linde, W.T. Abraham, M.R. Gold, M. St John Sutton, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834 1843
9. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
10. J.G. Cleland, J.C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
11. A.S. Tang, G.A. Wells, and M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
12. E. Diaz-Infante, L. Mont, and J. Leal Predictors of lack of response to resynchronization therapy Am J Cardiol 95 2005 1436 1440